Barata, P. C., Corrigan, J., Culnan, J., Dulberger, K. N., La, J., Akama-Garren, E., DuMontier, C., Hansen, J. E., Bitting, R. L., Cheng, H. H., Cooperberg, M. R., Dorff, T. B., Halabi, S., Loeb, S., Nanus, D. M., Pan, C., Schoen, M. W., Fillmore, N., Paller, C. J., Rettig, M. (2025). Docetaxel rechallenge versus cabazitaxel in patients previously treated with docetaxel for metastatic castrate-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.5_suppl.154